Sort   by:  
 Page size 
ProteomicsProteogenomic subtyping of acute myeloid leukemia and ex-vivo drug response profiling for precision therapies.
We have performed a comprehensive proteomic analysis of clinical patient samples of acute myeloid leukemia (AML) alongside genome-, transcriptome- and ex-vivo drug response profiling.
ORGANISM(S): Homo sapiens (Human) 
2026-03-23 | PXD061758 | Pride
Aml Cancer Proteomics Leukemia Drug screening Therapy 
UnknownExome and immune cell score analyses reveal great variation within synchronous primary colorectal cancers.
Not available
S-EPMC6734647 | biostudies-literature
UnknownLife-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
Not available
S-EPMC8542445 | biostudies-literature
UnknownDutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study.
Not available
S-EPMC7540213 | biostudies-literature
UnknownSixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
Not available
S-EPMC8495602 | biostudies-literature
Sort   by:  
 Page size